SCHEMBL3554269

SCHEMBL3554269

ON=C1c2ccccc2-c2c1cccc2-c1nc2cccnc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.43
CDK2 P24941 1/20 0.43
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
HSP90AB1 P08238 3/20 0.42
NPSR1 Q6W5P4 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPK10 P53779 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.42
PTK2B Q14289 2/20 0.42
NCOA1 Q15788 2/20 0.42
NCOA3 Q9Y6Q9 2/20 0.42
TSHR P16473 2/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 6/20 0.40
FGFR1 P11362 1/20 0.39
FLT1 P17948 1/20 0.39
ALDH1A1 P00352 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3554267 1.00 CDK1 (0.43) CDK1CDK2MKNK1MKNK2HSP90AB1
SCHEMBL2311295 0.82 MEN1 (0.40) CDK1CDK2MKNK1MKNK2HSP90AB1
SCHEMBL2311299 0.82 MEN1 (0.40) CDK1CDK2MKNK1MKNK2HSP90AB1
SCHEMBL2309662 0.82 RAB9A (0.55) CDK1CDK2MKNK1MKNK2NPSR1
SCHEMBL12431585 0.82 RAB9A (0.55) CDK1CDK2MKNK1MKNK2NPSR1
SCHEMBL2309658 0.82 RAB9A (0.55) CDK1CDK2MKNK1MKNK2NPSR1
SCHEMBL2315903 0.80 CDK1 (0.43) CDK1CDK2MKNK1MKNK2HSP90AB1
SCHEMBL2308803 0.80 PDE5A (0.57) HSP90AB1SMN1; SMN2KDM4EFGFR1FLT1
SCHEMBL2308802 0.80 PDE5A (0.57) HSP90AB1SMN1; SMN2KDM4EFGFR1FLT1
SCHEMBL2313200 0.80 PDE5A (0.57) HSP90AB1SMN1; SMN2KDM4EFGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 CDK1 2875/4885CDK2 2439/4885MKNK1 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.